Using AI-Based Analysis of ECGs and Multimodality Datasets to Improve Diagnosis of Valvular Heart Disease, Cardiac Amyloidosis, and Heart Failure

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Equity/Stock(s)/Options (Personal) - Abbott Laboratories; Baxter International
• Grant Support/Research Contract (Institutional) - Eidos Therapeutics; Pfizer; Edwards Lifesciences; Janssen